Effects of Lactococcus lactis on composition of intestinal microbiota: role of nisin.
This study examined the ability of (i) pure nisin, (ii) nisin-producing Lactococcus lactis strain CHCC5826, and (iii) the non-nisin-producing L. lactis strain CHCH2862 to affect the composition of the intestinal microbiota of human flora-associated rats. The presence of both the nisin-producing and the non-nisin-producing L. lactis strains significantly increased the number of Bifidobacterium cells in fecal samples during the first 8 days but decreased the number of enterococci/streptococci in duodenum, ileum, cecum, and colon samples as detected by selective cultivation. No significant changes in the rat fecal microbiota were observed after dosage with nisin. Pearson cluster analysis of denaturing gradient gel electrophoresis profiles of the 16S rRNA genes present in the fecal microbial population revealed that the microbiota of animals dosed with either of the two L. lactis strains were different from that of control animals dosed with saline. However, profiles of the microbiota from animals dosed with nisin did not differ from the controls. The concentrations of nisin estimated by competitive enzyme-linked immunosorbent assay (ELISA) were approximately 10-fold higher in the small intestine and 200-fold higher in feces than the corresponding concentrations estimated by a biological assay. This indicates that nisin was degraded or inactivated in the gastrointestinal tract, since fragments of this bacteriocin are detected by ELISA while an intact molecule is needed to retain biological activity.
Bernbom
Nete
N
Department of Microbiological Food Safety, Danish Institute for Food and Veterinary Research, Mørkhøj Bygade 19, DK-2860 Søborg, Denmark.
Licht
Tine Rask
TR
Brogren
Carl-Henrik
CH
Jelle
Birthe
B
Johansen
Anette H
AH
Badiola
Iker
I
Vogensen
Finn K
FK
Nørrung
Birgit
B
D000362:Agar; D000818:Animals; D001644:Bifidobacterium / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism; D003470:Culture Media; D016983:Enterococcus / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism; D005243:Feces / Q000382:microbiology; D005856:Germ-Free Life; D006801:Humans; D007422:Intestines / Q000382:microbiology*; D013294:Lactococcus lactis / Q000378:metabolism*; D009561:Nisin / Q000378:metabolism* / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013291:Streptococcus / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism
D003470:Culture Media; D009561:Nisin; D000362:Agar